Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2013 | 1 |
2020 | 1 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Liver Cancer-Specific Serine Protease Inhibitor Kazal Is a Potentially Novel Biomarker for the Early Detection of Hepatocellular Carcinoma.
Clin Transl Gastroenterol. 2020 Dec;11(12):e00271. doi: 10.14309/ctg.0000000000000271.
Clin Transl Gastroenterol. 2020.
PMID: 33512798
Free PMC article.
Three-Dimensional Structure of Novel Liver Cancer Biomarker Liver Cancer-Specific Serine Protease Inhibitor Kazal (LC-SPIK) and Its Performance in Clinical Diagnosis of Hepatocellular Carcinoma (HCC).
Lu F, Ott C, Bista P, Lu X.
Lu F, et al.
Diagnostics (Basel). 2024 Mar 29;14(7):725. doi: 10.3390/diagnostics14070725.
Diagnostics (Basel). 2024.
PMID: 38611638
Free PMC article.
Review.
Item in Clipboard
Screening and identification of compounds with antiviral activity against hepatitis B virus using a safe compound library and novel real-time immune-absorbance PCR-based high throughput system.
Lamontagne J, Mills C, Mao R, Goddard C, Cai D, Guo H, Cuconati A, Block T, Lu X.
Lamontagne J, et al.
Antiviral Res. 2013 Apr;98(1):19-26. doi: 10.1016/j.antiviral.2013.02.001. Epub 2013 Feb 13.
Antiviral Res. 2013.
PMID: 23415884
Free PMC article.
Item in Clipboard
Cite
Cite